Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NEBIVOLOL AND AMLODIPINE COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/055984
Kind Code:
A1
Abstract:
Provided is a nebivolol and amlodipine composition, which comprises nebivolol and amlodipine. The nebivolol comprises one or more of nebivolol, a pharmaceutically acceptable salt thereof, and a solvate thereof. The amlodipine comprises one or more of amlodipine, a pharmaceutically acceptable salt thereof, and a solvate thereof. A nebivolol and amlodipine compound preparation is beneficial to improving the blood pressure reduction effect, improving the safety and tolerance, and reducing side effects. Compared with single medicines of nebivolol and amlodipine, the combination of nebivolol and amlodipine has the advantages that: the number of medicines taken is reduced, and the compliance of a patient is improved; the medicine-taking compliance of old people or people with dysphagia can be facilitated; a plasma concentration in vivo is maintained to be stable, the blood pressure of a hypertension patient is maintained to be stable for a long time, and the side effects of the single medicines are reduced; and it is avoided that a patient stops taking medicine at will, and disease recurrence and progression of malignant complications are prevented.

Inventors:
GUO ZHEN (CN)
XIE WENFENG (CN)
CHEN ZUYOU (CN)
WANG TINGTING (CN)
YING SHUHUAN (CN)
Application Number:
PCT/CN2023/118513
Publication Date:
March 21, 2024
Filing Date:
September 13, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI YONSUN BIOTECHNOLOGY CO LTD (CN)
International Classes:
A61K31/4422; A61K31/353; A61P9/00; A61P9/04; A61P9/12
Foreign References:
CN101766611A2010-07-07
CN103566372A2014-02-12
CN108463250A2018-08-28
Other References:
SUN YING-XIAN: "Research progress of new drugs for the treatment of hypertension", CHINESE JOURNAL OF PRACTICAL INTERNAL MEDICINE, vol. 35, no. 4, 1 April 2015 (2015-04-01), pages 290 - 294, XP093147969, ISSN: 1005-2194, DOI: 10.7504/nk2015030303
SULTAN EL-ZAHRAA M., RABEA HODA, ELBERRY AHMED A., MAHMOUD HESHAM B.: "Effect of Amlodipine/Nebivolol combination therapy on central BP and PWV compared to Amlodipine/Valsartan combination therapy", THE EGYPTIAN HEART JOURNAL, vol. 74, no. 1, 1 December 2022 (2022-12-01), XP093147971, ISSN: 2090-911X, DOI: 10.1186/s43044-022-00254-0
SHAIKH, S. A. ET AL.: "Formulation and Evaluation of S-(-)-Amlodipine Besylate and Nebivolol Hydrochloride Tablets", J. ADV. PHARM. TECH. RES., vol. 1, no. 2, 30 June 2010 (2010-06-30), pages 199 - 206, XP009160106
JALANDER DONAPATI, SANDEEP KOSIKA, PARAMESHWAR KONDAPURAM, RAMAKRISHNA B., SURESH CHINDAM: "A Comparative clinical study on the Combination Therapy of Nebivolol/Amlodipine with Atenolol/Amlodipin in the management of hypertension", ASIAN JOURNAL OF PHARMACY AND PHARMACOLOGY, vol. 4, no. 1, 1 February 2018 (2018-02-01), pages 38 - 44, XP093147974, ISSN: 2455-2674, DOI: 10.31024/ajpp.2018.4.1.7
Attorney, Agent or Firm:
BEIJING ORIGINTELLIGENCE IP LAW FIRM (CN)
Download PDF: